Viewing Study NCT04169932

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:00 PM
Ignite Modification Date: 2026-02-23 @ 8:57 PM
Study NCT ID: NCT04169932
Status: UNKNOWN
Last Update Posted: 2019-11-20
First Post: 2019-11-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: The Clinical Study of CD20 CAR-T Cells in Patients With Relapsed and Refractory B Cell Non-Hodgkin Lymphoma
Sponsor: Shanghai Longyao Biotechnology Inc., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed and Refractory B Cell Lymphoma View
None Non-Hodgkin Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CD20 CAR T Cells View
None Safety, tolerance and efficacy View